| Ytd | -54.30% | |
| 1y | -44.78% |
| Open | 0.78 | Prev Close | 0.74 | Low | 0.76 | High | 0.80 | Mkt Cap | 54.94M |
| Vol | 3.55M | Avg Vol | 2.71M | EPS | -1.02 | P/E | -0.78 | Forward P/E | -0.48 |
| Beta | 1.52 | Short Ratio | 11.22 | Inst. Own | 33.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.05 | 200-d Avg | 1.53 | 1yr Est | 10.67 |
INO News
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company fo
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular
US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%,
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares
INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29
PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a b
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio
PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a b
NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is invest
Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcrip
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law
PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company fo
Inovio Pharmaceuticals NASDAQ: INO shareholders approved all proposals presented at the company's 20
Results provide important clinical evidence to support ApolloBio's future regulatory submission in C
https://www.cdc.gov/ebola/situation-summary/index.html
Inovio Pharmaceuticals remains a high-risk, event-driven play, with the investment case dominated by
Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript
Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated appro
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak.
PLYMOUTH MEETING, Pa., May 8, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focu
PLYMOUTH MEETING, Pa., May 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focu
VRTX heads into Q1 earnings with Trikafta demand, rising Alyftrek sales, and Casgevy and Journavx sa
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(200
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $
Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted be
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
On Thursday, 369 companies hit new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni